A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
NCT07363330
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Recurrent
Metastatic
Interventions
DRUG:
Utidelone plus Toripalimab
Sponsor
Zhongnan Hospital